RAS Signaling in Colorectal Carcinomas through Alteration of RAS, RAF, NF1, and/or RASSF1A
More than half of all colorectal carcinomas are known to exhibit an activated mitogen-activated protein kinase pathway. The NF1 gene, a negative regulator of KRAS, has not previously been examined in a series of colorectal cancer. In the present study, primary colorectal carcinomas stratified accord...
Main Authors: | Terje Ahlquist, Irene Bottillo, Stine A. Danielsen, Gunn I. Meling, Torleiv O. Rognum, Guro E. Lind, Bruno Dallapiccola, Ragnhild A. Lothe |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2008-07-01
|
Series: | Neoplasia: An International Journal for Oncology Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1476558608800061 |
Similar Items
-
Gene methylation profiles of normal mucosa, and benign and malignant colorectal tumors identify early onset markers
by: Vatn Morten, et al.
Published: (2008-12-01) -
Genetic and Epigenetic Changes of Components Affecting the WNT Pathway in Colorectal Carcinomas Stratified by Microsatellite Instability
by: Lin Thorstensen, et al.
Published: (2005-02-01) -
KRAS interaction with RAF1 RAS-binding domain and cysteine-rich domain provides insights into RAS-mediated RAF activation
by: Timothy H. Tran, et al.
Published: (2021-02-01) -
Hypermethylated <it>MAL </it>gene – a silent marker of early colon tumorigenesis
by: Kallioniemi Anne, et al.
Published: (2008-03-01) -
RAF inhibitors promote RAS-RAF interaction by allosterically disrupting RAF autoinhibition
by: Ting Jin, et al.
Published: (2017-10-01)